Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
作者： JUDD W. MOUL , ROGER R. CONNELLY , DEBORAH P. LUBECK , JOHN J. BAUER , LEON SUN
DOI: 10.1016/S0022-5347(05)65761-8
关键词:
摘要: Purpose: Biostatistical models to predict stage or outcome in patients with clinically localized prostate cancer pretreatment specific antigen (PSA), Gleason sum on biopsy prostatectomy specimen, clinical pathological and other variables, including ethnicity, have been developed. However, date relied small subsets from academic centers military populations that may not be representative. Our study validates updates a model published previously the Cancer of Prostate Strategic Urologic Research Endeavor (CaPSURE, UCSF, Urology Outcomes Group TAP Pharmaceutical Products, Inc.), large multicenter, community based database Center for Disease (CPDR), database.Materials Methods: We validated biostatistical includes PSA, highest organ confinement status white black patients....
jurology.com 参考文章(26)
Myron Tanncnbaum, Urologic pathology: The prostate ,(1977)
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
Marie-Claude Bettencourt, John J. Bauer, Isabell A. Sesterhenn, F.K. Mostofi, DAvid G. McLeod, Judd W. Moul, Ki-67 Expression is a Prognostic Marker of Prostate Cancer Recurrence after Radical Prostatectomy The Journal of Urology. ,vol. 156, pp. 1064- 1068 ,(1996) , 10.1016/S0022-5347(01)65703-3
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Alan W. Partin, James L. Mohler, Steven Piantadosi, Charles B. Brendler, Martin G. Sanda, Patrick C. Walsh, Jonathan I. Epstein, Jonathan W. Simons, Fray F. Marshall, Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. Urology. ,vol. 45, pp. 831- 838 ,(1995) , 10.1016/S0090-4295(99)80091-0
MARIE-CLAUDE BETTENCOURT, JOHN J. BAUER, ISABELLA A. SESTERHENN, ROGER R. CONNELLY, JUDD W. MOUL, CD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY The Journal of Urology. ,vol. 160, pp. 459- 465 ,(1998) , 10.1016/S0022-5347(01)62925-2
M Kuczyk, S Machtens, K Hradil, J Schubach, W Christian, R Knüchel, J Hartmann, C Bokemeyer, U Jonas, J Serth, Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients British Journal of Cancer. ,vol. 81, pp. 1052- 1058 ,(1999) , 10.1038/SJ.BJC.6690806
John J. Bauer, Roger R. Connelly, Isabell A. Sesterhenn, Marie-Claude Bettencourt, David G. McLeod, Shiv Srivastava, Judd W. Moul, Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy Cancer. ,vol. 79, pp. 952- 962 ,(1997) , 10.1002/(SICI)1097-0142(19970301)79:5<952::AID-CNCR12>3.0.CO;2-1
Deborah P. Lubeck, Mark S. Litwin, James M. Henning, David M. Stier, Peter Mazonson, Ruth Fisk, Peter R. Carroll, The Capsure research panel, The capsure database: a methodology for clinical practice and research in prostate cancer Urology. ,vol. 48, pp. 773- 777 ,(1996) , 10.1016/S0090-4295(96)00226-9
Makoto Ohori, Thomas M. Wheeler, Peter T. Scardino, The new american joint committee on cancer and international union against cancer tnm classification of prostate cancer Cancer. ,vol. 74, pp. 104- 114 ,(1994) , 10.1002/1097-0142(19940701)74:1<104::AID-CNCR2820740119>3.0.CO;2-5